Silka Antifungal
Dosage form: cream
Ingredients: Terbinafine Hydrochloride 1g in 100g
Labeler: Genomma Lab USA, Inc.
NDC code: 50066-080
Medically reviewed by Drugs.com. Last updated on Jan 1, 2025.
Athlete's Foot
Drug Facts
Terbinafine hydrochloride 1%
Antifungal
- cures most athlete's foot (tinea pedis)
- cures most jock itch (tinea cruris) and ringworm (tinea corporis)
- relieves itching, burning, cracking and scaling which accompany these conditions
For external use only
- on nails or scalp
- in or near the mouth or the eyes
- for vaginal yeast infections
When using this product do not get into the eyes. If eye contact occurs, rinse thoroughly with water.
- too much irritation occurs or gets worse.
Keep out of reach of children. If swallowed, get medical help or contact a poison control center right away.
- adults and children 12 years and older
- use the tip of the cap to break the seal and open the tube
- wash the affected skin with soap and water and dry completely before applying.
- for athlete's foot wear well-fitting, ventilated shoes. Change shoes and socks at least once daily.
- between the toes only: apply twice a day (morning and night) for 1 week or as directed by a doctor.
- on the bottom or sides of the foot: apply twice a day (morning and night) for 2 weeks or as directed by a doctor.
- for jock itch and ringworm: apply once a day (morning or night) for 1 week or as directed by a doctor.
- wash hands after each use.
- children under 12 years: ask a doctor.
- do not use if seal on tube is broken or is not visible
- store at controlled room temperature 20° to 25°C (68° to 77°F)
- see carton or tube crimp for lot number and expiration date
benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol.
1 877 99 GENOM (43666) Monday to Friday, 8 am to 6 pm Central time.
Distributed by
Genomma Lab USA Inc., Houston, TX, 77027
SILKA
ANTIFUNGAL
terbinafine hydrochloride cream |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
Labeler - Genomma Lab USA, Inc. (832323534) |
Registrant - Taro Pharmaceuticals U.S. A., Inc. (145186370) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Taro Pharmaceuticals Inc. | 206263295 | MANUFACTURE(50066-080) |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.